期刊文献+

microRNA-133a与骨质疏松症

microRNA-133a and osteoporosis
下载PDF
导出
摘要 骨质疏松症是以骨强度下降和骨折风险增加为特征的常见骨骼疾病,微小RNA(microRNA,miRNA)在骨质疏松症的病因及分子生物学机制中扮演着重要角色,明确其功能及作用机制将为骨质疏松症的诊断与防治提供新的思路与靶点。本文对microRNA-133a在骨质疏松中的相关作用机制进行综述,系统阐述microRNA-133a与骨质疏松症发生的对应关系及其在成骨和破骨分化中的具体作用机制,以期为临床治疗和基础研究提供一定的借鉴。 Osteoporosis is a common bone disease characterized by decreased bone strength and increased risk of fracture.MicroRNA plays an important role in the etiology and molecular biological mechanisms of osteoporosis.Clarifying its function and mechanism of action will provide new ideas and targets for the diagnosis,prevention,and treatment of osteoporosis.In this article,the relevant mechanisms of microRNA-133a in osteoporosis will be reviewed,and the corresponding relationship between microRNA-133a and the occurrence of osteoporosis as well as the specific mechanisms of microRNA-133a in osteoblast and osteoclast differentiation will be systematically elaborated,with a view to providing certain reference for clinical treatment and basic research.
作者 万里甫 王刚 张月雷 WAN Li-fu;WANG Gang;ZHANG Yue-lei(Department of Orthopaedics,The First Affiliated Hospital of Anhui Medical University,Hefei 230000,China)
出处 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2021年第6期668-673,共6页 Chinese Journal Of Osteoporosis And Bone Mineral Research
基金 国家自然科学基金(81702134) 安徽医科大学校基金临床科学基金(2020xkj183)。
关键词 骨质疏松症 微小RNA-133a 骨髓间充质干细胞 成骨细胞 破骨细胞 osteoporosis microRNA-133a bone marrow mesenchyml stem cell osteoblast osteoclast
  • 相关文献

参考文献9

二级参考文献89

  • 1林坚涛,吴铁,崔燎,于琼,郭震,陈志东.玉屏风水提液对环磷酰胺致大鼠骨质疏松骨形态计量学的影响[J].辽宁中医杂志,2007,34(8):1159-1161. 被引量:3
  • 2胥少汀,葛宝丰,徐印坎.实用骨科学[M].第4版.北京:人民军医出版社,2012:1857.
  • 3LAI B M,CHEUN C L, LUK K D, et al. Estrogen receptor alpha CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postm- enopausal women [J]. Osteoporos Int, 2008,19 (4) : 571.
  • 4KUMAR A, SINGH A K, GAUTAM A K, et al. Identifica- tion of kaempferol-regulated proteins in rat calvarial osteo- blasts during mineralization by proteomics[ J]. Proteomics, 2010,10(9) :1730.
  • 5TAKADA I,KOUZMENKO A P,KATO S. Molecular switc- hing of osteoblastogenesis versus adipogenesis: implications for targeted therapies[J]. Expert Opin Ther Targets,2009, 13(5) :593.
  • 6EUI-SIC C, MYOUNG-KYUN K, YOUNG-OK S, et al. The effect of Rosiglitazone on osteoblastic differentiation, osteo- clast formation and bone resorption [ J ]. Molecules and Cells ,2012,33 : 173.
  • 7HARD E,LAPLANTINE E, GEOFFROY V,et al. N-Cad- herin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling osteoblast function and bone formation[J1. Mol Cell Bio,2009,29(4) :953.
  • 8MONROE D G, MCGEE-LAWRENCE M E, OURSLER M J,et al. Update on Wnt signaling in bone cell biology and bone disease[ J]. Gene,2012,492( 1 ) : 1.
  • 9ALMEIDA M. Unraveling the role of FoxOs in bone-in- sights from mouse models[J]. Bone,2011,49(3) :319.
  • 10LI F,NIYIBIZI C. Cells derived from murine induced pluri- potent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblast differentiation and form bone in vivo[ J). BMC Cell Biology,2012,13:35.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部